Рет қаралды 684
Harlan Krumholz, MD, FACC, incoming Editor-in-Chief of JACC interviews Mikhail Kosiborod, MD, FACC, about Semaglutide and NTproBNP in Obesity-Related HFpEF and shares insights from the STEP-HFpEF Trial. This paper was simultaneously published in JACC to coincide with research presented during ESC Heart Failure 2024.
Related article: www.jacc.org/d...
#jacc #jaccjournals